Search Results - "Sonabend, A"

Refine Results
  1. 1

    Convection-Enhanced Delivery by Mehta, A. M., Sonabend, A. M., Bruce, J. N.

    Published in Neurotherapeutics (01-04-2017)
    “…Convection-enhanced delivery (CED) is a promising technique that generates a pressure gradient at the tip of an infusion catheter to deliver therapeutics…”
    Get full text
    Journal Article Book Review
  2. 2

    A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies by Chang, P D, Malone, H R, Bowden, S G, Chow, D S, Gill, B J A, Ung, T H, Samanamud, J, Englander, Z K, Sonabend, A M, Sheth, S A, McKhann, 2nd, G M, Sisti, M B, Schwartz, L H, Lignelli, A, Grinband, J, Bruce, J N, Canoll, P

    Published in American journal of neuroradiology : AJNR (01-05-2017)
    “…The complex MR imaging appearance of glioblastoma is a function of underlying histopathologic heterogeneity. A better understanding of these correlations,…”
    Get full text
    Journal Article
  3. 3

    Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo by Tyler, M A, Ulasov, I V, Sonabend, A M, Nandi, S, Han, Y, Marler, S, Roth, J, Lesniak, M S

    Published in Gene therapy (01-02-2009)
    “…Adenoviral oncolytic virotherapy represents an attractive treatment modality for central nervous system (CNS) neoplasms. However, successful application of…”
    Get full text
    Journal Article
  4. 4

    Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo by Ulasov, I V, Sonabend, A M, Nandi, S, Khramtsov, A, Han, Y, Lesniak, M S

    Published in British journal of cancer (07-04-2009)
    “…Conditionally replicative adenoviruses (CRAds) represent a novel treatment strategy for malignant glioma. Recent studies suggest that the cytopathic effect…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats by Sonabend, A M, Ulasov, I V, Han, Y, Rolle, C E, Nandi, S, Cao, D, Tyler, M A, Lesniak, M S

    Published in Cancer gene therapy (01-04-2009)
    “…Conditionally replicative adenoviruses (CRAds) are often evaluated in mice; however, normal and cancerous mouse tissues are poorly permissive for human CRAds…”
    Get full text
    Journal Article
  7. 7

    Intrahepatic DNA Vaccination: Unexpected Increased Resistance Against Murine Cysticercosis Induced by Non-specific Enhanced Immunity by Cruz-Revilla, C, Sonabend, A. M, Rosas, G, Toledo, A, Meneses, G, Lopez-Casillas, F, Hernández, B, Fragoso, G, Sciutto, E

    Published in The Journal of parasitology (01-06-2006)
    “…Experimental murine cysticercosis caused by Taenia crassiceps has proved to be a useful model with which to test the efficacy of new vaccine candidates and…”
    Get full text
    Journal Article
  8. 8

    OS08.6.A Novel role of ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM by Budhiraja, S, Baisiwala, S, Perrault, E, Cho, S, Dara, G, Nandoliya, K, Zolp, A, Chen, L, Dmello, C, Park, C, Sonabend, A, Ahmed, A

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background Glioblastoma (GBM) is the most common type of adult malignant brain tumor, with a median survival of only 21 months. This is partly due to…”
    Get full text
    Journal Article
  9. 9

    OS07.3.A Phase 1/2 clinical trial of blood-brain barrier opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients receiving IV carboplatin by Idbaih, A, Sonabend, A, Stupp, R, Chinot, O, Dufour, H, Ducray, F, Menei, P, de Groot, J, Desseaux, C, Carpentier, A

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background Low intensity pulsed ultrasound (LIPU) in combination with microbubbles is a promising approach for brain drug delivery. A phase 1/2…”
    Get full text
    Journal Article
  10. 10

    JS07.4.A REGIONAL B-CELL MEDIATED IMMUNOSUPPRESSION IDENTIFIED THROUGH SPATIAL AND SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF CHORDOMA by Kada Benotmane, J, Arrieta, V A, Zhao, J, Hou, D, Katz, J, Pandey, S, Cholak, M, Sonabend, A, Horbinski, C, Miska, J, Stupp, R, Lesniak, M, Heiland, D, Chang, C

    Published in Neuro-oncology (Charlottesville, Va.) (08-09-2023)
    “…Abstract BACKGROUND Chordomas, rare indolent neoplasms, mainly occur in the skull base or lower spine. Therapies, including surgery and radiotherapy, often…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    The Role of Regulatory T Cells in Malignant Glioma by SONABEND, Adam M, ROLLE, Cleo E, LESNIAK, Maciej S

    Published in Anticancer research (01-03-2008)
    “…The aggressive nature of gliomas is closely related to their capacity to evade the anti-tumoral immune response. The mechanisms implicated in this phenomenon…”
    Get full text
    Journal Article
  16. 16

    A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery by Yun, Jonathan, Sonabend, Adam M, Ulasov, Ilya V, Kim, Dong-Hyun, Rozhkova, Elena A, Novosad, Valentyn, Dashnaw, Stephen, Brown, Truman, Canoll, Peter, Bruce, Jeffrey N, Lesniak, Maciej S

    Published in Journal of clinical neuroscience (01-06-2012)
    “…Abstract In vivo tracking of gene therapy vectors challenges the investigation and improvement of biodistribution of these agents in the brain, a key feature…”
    Get full text
    Journal Article
  17. 17

    ET-57 TOPOISOMERASE II IN PRONEURAL GLIOMAS, A MODULATOR OF TRANSCRIPTION AND A THERAPEUTIC TARGET by Sonabend, A. M., Carminucci, A. S., Amendolara, B., Bansal, M., Praver, M., Realubit, R., Li, H., Karan, C., Banu, M., Lei, L., Califano, A., Canoll, P., Bruce, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Topoisomerase II (TOP2) is highly expressed on proneural gliomas, but its specific function on these tumors is unknown. We found that TOP2 is expressed in…”
    Get full text
    Journal Article
  18. 18

    IMAGE GUIDED RNA-SEQ REVEALS SUBTYPE-SPECIFIC PATTERNS AT THE INFILTRATIVE MARGINS OF GLIOBLASTOMA by Canoll, P., Sims, P., Gil, B., Pisapia, D., Malone, H., Goldstein, H., Lei, L., Sonabend, A., Yun, J., Samanamud, J., Sims, J., Teich, A., Sheth, S., McKhann, G., Sisti, M., Bruce, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-07-2014)
    “…BACKGROUND: The primary treatment of GBM is surgical resection of the contrast enhancing mass, while regions of non-enhancing tumor are left behind, and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma by Sonabend, Adam M, Velicu, Simona, Ulasov, Ilya V, Han, Yu, Tyler, Betty, Brem, Henry, Matar, Majed M, Fewell, Jason G, Anwer, Khursheed, Lesniak, Maciej S

    Published in Anti-cancer drugs (01-02-2008)
    “…Interleukin-12 (IL-12) triggers an antitumoral immune response and an antiangiogenic effect against cancer. In this study, we tested a novel polymeric vehicle…”
    Get full text
    Journal Article